{"id":357371,"date":"2023-06-08T17:40:34","date_gmt":"2023-06-08T21:40:34","guid":{"rendered":"https:\/\/www.sgtreport.com\/?p=357371"},"modified":"2023-06-08T01:53:39","modified_gmt":"2023-06-08T05:53:39","slug":"10-things-you-need-to-know-about-dna-rna-vaccines-for-livestock","status":"publish","type":"post","link":"https:\/\/www.sgtreport.com\/2023\/06\/10-things-you-need-to-know-about-dna-rna-vaccines-for-livestock\/","title":{"rendered":"10 Things You Need to Know About DNA &#038; RNA Vaccines for Livestock"},"content":{"rendered":"<p><em>by The Sharp Edge, <a href=\"https:\/\/www.coreysdigs.com\/food-supply-chain\/10-things-you-need-to-know-about-dna-rna-vaccines-for-livestock\/\" target=\"_blank\" rel=\"noopener\">Corey&#8217;s Digs<\/a>:<\/em><\/p>\n<p><img decoding=\"async\" class=\"alignleft\" style=\"width: 35%;\" src=\"https:\/\/www.coreysdigs.com\/wp-content\/uploads\/2023\/06\/DNA_RNA_Livestock-1536x943.jpg\" alt=\"\" \/><\/p>\n<h5>1. What are the different terms used for DNA or RNA-based veterinary biologics?<\/h5>\n<p>Not all genetic technologies used in veterinary medicine fall under the categories of \u201cmRNA vaccines\u201d or \u201cmRNA gene therapies.\u201d\u00a0 There are other terms to look out for when it comes to genetic technologies for veterinary medicine.\u00a0 These terms also include:<\/p>\n<ul>\n<li>\u201cRNA Particle Technology\u201d<\/li>\n<li>\u201cRNA Particle Platform\u201d<\/li>\n<li>\u201cDNA Vaccine\u201d<\/li>\n<li>\u201cDNA Immunostimulant\u201d<\/li>\n<li>\u201cPrescription Platform Product\u201d<\/li>\n<\/ul>\n<p><!--more Read More--> TRUTH LIVES on at\u00a0<a href=\"https:\/\/sgtreport.tv\/\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\">https:\/\/sgtreport.tv\/<\/a><\/p>\n<div class=\"wp-block-spacer\" aria-hidden=\"true\"><\/div>\n<h5>2. How do DNA or RNA-based veterinary biologics work?<\/h5>\n<p>With\u00a0<a href=\"https:\/\/www.merck-animal-health-usa.com\/offload-downloads\/merck-sequivity-white-paper#:~:text=With%20SEQUIVITY%20RNA%20Particle%20Technology,proteins%20which%20act%20as%20antigens.\" target=\"_blank\" rel=\"noreferrer noopener\">SEQUIVITY\u2019s RNA Particle Technology<\/a>, a \u201cgene of interest provides instructions\u201d to the immune cells which \u201ctranslate the sequence into proteins\u201d that \u201cact as antigens.\u201d This triggers an immune response.<\/p>\n<p>As for\u00a0<a href=\"https:\/\/www.prnewswire.com\/news-releases\/first-dna-vaccine-licensed-for-chickens-300554855.html\" target=\"_blank\" rel=\"noreferrer noopener\">AgriLab\u2019s ExactVac DNA technology<\/a>, \u201cthe vaccine is produced by splicing a gene for a specific antigen\u201d into \u201ca bacterial plasmid\u201d which \u201cis then multiplied, purified and administered\u201d for \u201cdelivery into target cells, where antigens produced by the plasmid elicit an immune response.\u201d<\/p>\n<p>Bayer\u2019s\u00a0<a href=\"https:\/\/www.youtube.com\/watch?v=3hgUNibH-Ng\" target=\"_blank\" rel=\"noreferrer noopener\">Zelnate DNA immunostimulant<\/a>\u00a0is \u201cmade up of a special type of immunostimulatory DNA surrounded by a lipid carrier or liposome\u201d which is then \u201cengulfed by the animal\u2019s immune cell\u201d where the \u201cliposome breaks down exposing the DNA\u201d and the \u201cpathogen-associated molecular pattern\u201d of the DNA \u201cattaches to the immune cell\u2019s toll-like receptors triggering activation of the immune cell.\u201d<\/p>\n<div class=\"wp-block-spacer\" aria-hidden=\"true\"><\/div>\n<h5>3. Which agency approves veterinary biologics?<\/h5>\n<p>The USDA\u2019s\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/aphis\/ourfocus\/animalhealth\/veterinary-biologics\/ct_vb_licensed_products\" target=\"_blank\" rel=\"noreferrer noopener\">Animal and Plant Health Inspection Service (APHIS)<\/a>\u00a0and their Center for Veterinary Biologics is responsible for approving veterinary biological products including vaccines and DNA or RNA-based biologics. Here are the lists of the currently licensed\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/currentprodcodebook.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">veterinary biological products<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/aquaproducts.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">biologics for aquatic animals<\/a>.<\/p>\n<div class=\"wp-block-spacer\" aria-hidden=\"true\"><\/div>\n<h5>4. Which DNA or RNA-based biologics have been approved for food animals?<\/h5>\n<p>There are several DNA and RNA-based genetic technologies that have received USDA approval or conditional approval for use on chickens, cows, fish, and pigs as outlined below.<\/p>\n<h6>Chickens<\/h6>\n<ul>\n<li>In September 2015, Harrisvaccines received a\u00a0<a href=\"https:\/\/www.merck-animal-health.com\/blog\/2015\/09\/21\/harrisvaccines-receives-usda-conditional-license-for-avian-influenza-vaccine-rna\/\" target=\"_blank\" rel=\"noreferrer noopener\">USDA conditional license<\/a>\u00a0for an RNA-based avian influenza vaccine. Harrisvaccines \u201cemploys their unique SirraVaxSM RNA Particle (RP) technology platform\u201d which can be updated to match current and future avian flu strains. In October 2015, Harrisvaccines was awarded a\u00a0<a href=\"https:\/\/www.merck-animal-health.com\/blog\/2015\/10\/14\/harrisvaccines-awarded-avian-influenza-stockpile-contract-from-usda\/\" target=\"_blank\" rel=\"noreferrer noopener\">USDA stockpile contract<\/a>\u00a0of 48 million doses of their \u201cpioneering RNA particle vaccine.\u201d\u00a0 In November 2015,\u00a0<a href=\"https:\/\/www.merck.com\/news\/merck-animal-health-to-acquire-harrisvaccines\/\" target=\"_blank\" rel=\"noreferrer noopener\">Merck acquired Harrisvaccines<\/a>.<\/li>\n<li>In November 2017, AgriLabs received\u00a0<a href=\"https:\/\/www.prnewswire.com\/news-releases\/first-dna-vaccine-licensed-for-chickens-300554855.html\" target=\"_blank\" rel=\"noreferrer noopener\">USDA conditional approval<\/a>\u00a0for \u201cthe first DNA vaccine ever licensed for chickens\u201d\u00a0for avian flu using \u201cAgriLabs\u2019 ExactVac\u00a0DNA technology with ENABL\u00a0adjuvant.\u201d\u00a0 In January 2018,\u00a0<a href=\"https:\/\/www.huvepharma.com\/news\/article\/huvepharma-acquires-agrilabs\/\" target=\"_blank\" rel=\"noreferrer noopener\">Huvepharma acquired AgriLabs<\/a>.\u00a0 Huvepharma\u2019s DNA-based avian influenza vaccine has a conditional license on APHIS\u2019s most recent list of approved\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/currentprodcodebook.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">veterinary biological products<\/a>.<\/li>\n<\/ul>\n<h6>Cows<\/h6>\n<ul>\n<li>Bayer\u2019s\u00a0<a href=\"https:\/\/www.youtube.com\/watch?v=3hgUNibH-Ng\" target=\"_blank\" rel=\"noreferrer noopener\">Zelnate DNA Immunostimulant<\/a>\u00a0received\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/aphis\/ourfocus\/animalhealth\/veterinary-biologics\/product-summaries\/vet-label-data\/5cd25c45-753a-4614-b453-07ce96dc489e\" target=\"_blank\" rel=\"noreferrer noopener\">USDA approval<\/a>\u00a0for use against bovine respiratory disease (BRD) in January 2014. Zelnate is the \u201c<a href=\"https:\/\/www.bovinevetonline.com\/news\/new-products\/bayer-introduces-first-its-kind-immunostimulant-treat-brd\" target=\"_blank\" rel=\"noreferrer noopener\">first-of-its-kind<\/a>\u201d DNA immunostimulant that is a genetic technology rather than a vaccine or antibiotic.\u00a0 Bayer\u2019s DNA immunostimulant is on APHIS\u2019s most recent list of approved\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/currentprodcodebook.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">veterinary biological products<\/a>.<\/li>\n<\/ul>\n<h6>Fish<\/h6>\n<ul>\n<li>Elanco\u2019s Apex IHN DNA vaccine for salmonids against Infectious Hematopoietic Necrosis Virus (IHNV) has received USDA approval and is on APHIS\u2019s most recent list of licensed\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/aquaproducts.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">biologics for aquatic animals<\/a>.\u00a0 Elanco\u2019s\u00a0<a href=\"https:\/\/www.elancoaquaglobal.com\/us\/en\/innovation\" target=\"_blank\" rel=\"noreferrer noopener\">DNA technology<\/a>\u00a0uses \u201crelevant genetic components of the virus\u201d that are inserted into a plasmid and injected into the muscle, after which the plasmid \u201cinstructs cells to produce antigens, which initiate an immune response.\u201d<\/li>\n<\/ul>\n<h6>Pigs<\/h6>\n<ul>\n<li>In June 2014, Harrisvaccines became the first in the nation to receive\u00a0<a href=\"https:\/\/www.biospace.com\/article\/releases\/harrisvaccines-becomes-first-in-the-nation-to-receive-united-states-department-of-agriculture-usda-conditional-license-for-pedv-vaccine-\/?s=104\" target=\"_blank\" rel=\"noreferrer noopener\">USDA conditional licensing<\/a>\u00a0for their RNA-based PEDv vaccine for pigs.\u00a0 In November 2015,\u00a0<a href=\"https:\/\/www.merck.com\/news\/merck-animal-health-to-acquire-harrisvaccines\/\" target=\"_blank\" rel=\"noreferrer noopener\">Merck acquired Harrisvaccines<\/a>.\u00a0 Merck\u2019s \u201cRNA particle platform\u201d for Coronavirus and Porcine Epidemic Diarrhea Vaccine (PEDv) has\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/aphis\/ourfocus\/animalhealth\/veterinary-biologics\/product-summaries\/Vet-Label-Data\/d5ae72d2-8c0d-4a55-87c1-a3900cae2f72\" target=\"_blank\" rel=\"noreferrer noopener\">conditional approval by the USDA<\/a>\u00a0and this product has conditional licensing on APHIS\u2019s most recent list of\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/currentprodcodebook.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">veterinary biological products<\/a>.<\/li>\n<li>In December 2017,\u00a0<a href=\"https:\/\/www.prnewswire.com\/news-releases\/first-dna-vaccine-licensed-for-chickens-300554855.html#:~:text=AgriLabs%27%20next%20targets%20of%20swine%20influenza%20and%20opportunities%20in%20cattle%20production.\" target=\"_blank\" rel=\"noreferrer noopener\">AgriLabs<\/a>\u00a0received\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/wcm\/connect\/e20487c1-b336-49e0-b230-63918467b4ca\/605-19a5d3.pdf?MOD=AJPERES&amp;CONVERT_TO=url&amp;CACHEID=ROOTWORKSPACE-e20487c1-b336-49e0-b230-63918467b4ca-n488vNO\" target=\"_blank\" rel=\"noreferrer noopener\">USDA approval<\/a>\u00a0for a DNA-based swine flu vaccine.\u00a0 In January 2018,\u00a0<a href=\"https:\/\/www.huvepharma.com\/news\/article\/huvepharma-acquires-agrilabs\/\" target=\"_blank\" rel=\"noreferrer noopener\">Huvepharma acquired AgriLabs<\/a>.\u00a0 Huvepharma\u2019s ExactVac DNA-based swine flu vaccine is on APHIS\u2019s most recent list of approved\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/currentprodcodebook.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">veterinary biological products<\/a>.<\/li>\n<li>In 2020, Huvepharma\u2019s DNA-based vaccine platform for pigs received\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/wcm\/connect\/d4c46b2d-460f-4435-b68e-f3692dd44c85\/605-9pp0r1.pdf?MOD=AJPERES&amp;CONVERT_TO=url&amp;CACHEID=ROOTWORKSPACE-d4c46b2d-460f-4435-b68e-f3692dd44c85-n3KJCG3\" target=\"_blank\" rel=\"noreferrer noopener\">USDA approval<\/a>\u00a0as a \u201cprescription platform product\u201d so that the \u201cmanufacturer may update the gene insert in this vaccine under expedited procedures to respond to emerging needs.\u201d Huvepharma\u2019s DNA-based swine vaccine platform has conditional licensing as a prescription product on APHIS\u2019s most recent list of approved\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/currentprodcodebook.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">veterinary biological products<\/a>.<\/li>\n<li>In 2020 and 2021,\u00a0<a href=\"https:\/\/www.merck-animal-health-usa.com\/species\/swine\/sequivity\" target=\"_blank\" rel=\"noreferrer noopener\">Merck\u2019s Sequivity RNA vaccines<\/a>\u00a0for strains of swine influenza, which use \u201c<a href=\"https:\/\/www.merck-animal-health-usa.com\/offload-downloads\/merck-sequivity-white-paper\" target=\"_blank\" rel=\"noreferrer noopener\">RNA particle technology,<\/a>\u201d were\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/aphis\/ourfocus\/animalhealth\/veterinary-biologics\/product-summaries\/vet-label-data\/d611b51a-9eca-4d56-9556-dcc61fb96d5f\" target=\"_blank\" rel=\"noreferrer noopener\">approved by the USDA<\/a>\u00a0and are on APHIS\u2019s most recent list of approved\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/currentprodcodebook.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">veterinary biological products<\/a>.<\/li>\n<li>Also in 2021, Merck\u2019s RNA particle technology, for use as a \u201cprescription platform product,\u201d was\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/wcm\/connect\/c8b5e7b8-bf29-442a-ad46-47a916512c17\/165a-9pp000.pdf?MOD=AJPERES\" target=\"_blank\" rel=\"noreferrer noopener\">conditionally approved by the USDA<\/a>\u00a0and has conditional licensing on APHIS\u2019s most recent list of\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/currentprodcodebook.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">veterinary biological products<\/a>.<\/li>\n<\/ul>\n<div class=\"wp-block-spacer\" aria-hidden=\"true\"><\/div>\n<h5>5. Is there ongoing research into DNA or RNA-based veterinary biologics?<\/h5>\n<p>There are a number of ongoing studies on DNA and RNA-based genetic technologies for veterinary medicine, as outlined below.<\/p>\n<ul>\n<li><a href=\"https:\/\/www.genengnews.com\/topics\/drug-discovery\/bayer-partners-with-biontech-to-develop-mrna-vaccines-drugs-for-animal-health\/\" target=\"_blank\" rel=\"noreferrer noopener\">Bayer Partners with BioNTech to Develop mRNA Vaccines, Drugs for Animal Health<\/a>, May 2016<\/li>\n<li><a href=\"https:\/\/portal.nifa.usda.gov\/web\/crisprojectpages\/0440187-development-of-a-self-amplifying-mrna-vaccine-for-african-swine-fever-and-classical-swine-fever.html\" target=\"_blank\" rel=\"noreferrer noopener\">Development of a Self-amplifying mRNA Vaccine for African Swine Fever and Classical Swine Fever<\/a>, Start Date: Jun 1, 2021, End Date: May 31, 2024<\/li>\n<li><a href=\"https:\/\/www.ars.usda.gov\/research\/project\/?accnNo=441516\" target=\"_blank\" rel=\"noreferrer noopener\">Development of mRNA-based Vaccines for Heterosubtypic Protection Against Infectious Bronchitis and Infectious Laryngotracheitis Viruses<\/a>, Start Date: Oct 1, 2021, End Date: Sep 30, 2023<\/li>\n<li><a href=\"https:\/\/www.mdpi.com\/1999-4915\/14\/2\/401\" target=\"_blank\" rel=\"noreferrer noopener\">mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases<\/a>, February 2022<\/li>\n<li><a href=\"https:\/\/portal.nifa.usda.gov\/web\/crisprojectpages\/1027610-novel-mrna-vaccine-technology-for-prevention-of-bovine-respiratory-syncytial-virus.html\" target=\"_blank\" rel=\"noreferrer noopener\">Novel mRNA Vaccine Technology for Prevention of Bovine Respiratory Syncytial Virus<\/a>, Start Date Oct 1, 2021, End Date Sep 30, 2026<\/li>\n<li><a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.654289\/full\" target=\"_blank\" rel=\"noreferrer noopener\">Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines<\/a>, April 2021<\/li>\n<li><a href=\"https:\/\/www.ars.usda.gov\/research\/project\/?accnNo=442749\" target=\"_blank\" rel=\"noreferrer noopener\">Vaccines to Reduce Salmonella Infantis in Chickens<\/a>, Start Date: Sep 1, 2022, End Date: Oct 1, 2024<\/li>\n<\/ul>\n<div class=\"wp-block-spacer\" aria-hidden=\"true\"><\/div>\n<h5>6. Is it possible for mRNA vaccines in livestock to contaminate meat, dairy or egg products?<\/h5>\n<p>According to a recent\u00a0<a href=\"https:\/\/www.theepochtimes.com\/the-shocking-truth-about-edible-mrna-vaccines-in-our-food-part-2-facts-matter_5254263.html?utm_source=Morningbrief&amp;src_src=Morningbrief&amp;utm_campaign=mb-2023-05-12&amp;src_cmp=mb-2023-05-12&amp;utm_medium=email&amp;est=17HJ06ulLIjOE8zq2Tih6mv7B9nvCkHLEEAUjThlFmPMZXgWkrEntBPx\" target=\"_blank\" rel=\"noreferrer noopener\">Epoch Times report<\/a>, a 2014 USDA presentation on\u00a0<a href=\"https:\/\/www.aphis.usda.gov\/animal_health\/emergency_management\/downloads\/ed_materials\/vac_overview_handout.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Vaccination for Contagious Diseases<\/a>\u00a0states that food animals receiving vaccines are subject to \u201cmandatory withdrawal periods prior to slaughter for human consumption. Animals may not be sent to market until the withdrawal time has elapsed. During the mandatory withdrawal time vaccinated animals or products from vaccinated animals may not enter the food chain.\u00a0 The withdrawal time is determined by the country in which the vaccine is licensed and stated in the product license.\u201d\u00a0 As the Epoch Times report notes, the USDA recognizes that there must be a waiting time between vaccination and slaughter for human consumption due to risks of contaminating the food supply.\u00a0 The USDA presentation\u00a0<em>does not<\/em>, however, acknowledge DNA or RNA-based biologics, but the same standard of waiting times likely applies, as evidenced by\u00a0<a href=\"https:\/\/www.drugs.com\/vet\/porcine-epidemic-diarrhea-vaccine-rna.html#:~:text=Do%20not%20vaccinate%20within%2021%20days%20before%20slaughter.\" target=\"_blank\" rel=\"noreferrer noopener\">Merck\u2019s RNA vaccine for pigs<\/a>, which states \u201cDo not vaccinate within 21 days before slaughter.\u201d\u00a0 However,\u00a0<a href=\"https:\/\/rumble.com\/v2homuy-emerald-robinson-with-dr.-mccullough-pandemic-ends-mrna-in-milk-project-nex.html\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Peter McCullough notes<\/a>\u00a0that mRNA technology \u201cis far more durable than we ever could\u2019ve imagined. \u00a0It lasts in the human body for months unchanged.\u201d\u00a0 Therefore, even with standard wait times, Dr. McCullough believes it is conceivable that mRNA technology administered to food animals could contaminate the food supply.<\/p>\n<p>With that said, the Epoch Times report found \u201c<em>zero\u00a0<\/em>peer-reviewed studies looking into the transmissibility of mRNA vaccines from livestock to humans via either milk or meat.\u201d\u00a0 Dr. Peter McCullough\u00a0<a href=\"https:\/\/petermcculloughmd.substack.com\/p\/novel-vaccine-technologies-in-veterinary\" target=\"_blank\" rel=\"noreferrer noopener\">has warned<\/a>\u00a0that developers of novel vaccine technologies for veterinary medicine are \u201cblinded with infatuation for molecular biology and have lost sight of biological product safety in the food supply\u201d adding that they have failed to acknowledge the \u201cpossibility of collateral impact to humans.\u201d\u00a0 In addition, Dr. McCullough\u00a0<a href=\"https:\/\/petermcculloughmd.substack.com\/p\/chinese-load-cows-milk-with-mrna\" target=\"_blank\" rel=\"noreferrer noopener\">has raised<\/a>\u00a0concerns regarding transmissibility based on a\u00a0<a href=\"https:\/\/www.biorxiv.org\/content\/10.1101\/2022.12.19.517879v1\" target=\"_blank\" rel=\"noreferrer noopener\">recent study<\/a>\u00a0which loaded cow\u2019s milk with mRNA, and by consuming the milk, mice were successfully administered a Covid vaccine.\u00a0 Dr. McCullough points out the \u201cconsiderable ethical issues\u201d this research presents, with a large segment of the public having \u201cstrong objections to mRNA in the food supply, particularly if it was done surreptitiously or with minimal labelling\/warnings.\u201d<\/p>\n<div class=\"wp-block-spacer\" aria-hidden=\"true\"><\/div>\n<h5>7. Are there labeling requirements for meats, dairy or eggs that may have been contaminated by DNA or RNA-based veterinary biologics?<\/h5>\n<p>The required labeling for meat, dairy and egg products is not transparent about possible exposure to DNA or RNA-based veterinary biologics.\u00a0 The USDA does, however, require \u201c<a href=\"https:\/\/www.ams.usda.gov\/rules-regulations\/be\" target=\"_blank\" rel=\"noreferrer noopener\">Bioengineered<\/a>\u201d labeling for foods that \u201ccontain detectable genetic material that has been modified through certain lab techniques and cannot be created through conventional breeding or found in nature.\u201d\u00a0 It is unclear whether the USDA\u2019s\u00a0<a href=\"https:\/\/www.ams.usda.gov\/rules-regulations\/be\/validation-process\" target=\"_blank\" rel=\"noreferrer noopener\">testing process<\/a>\u00a0for \u201cdetectable genetic material\u201d is capable of picking up traces of genetic material from biologics used in veterinary medicine.<\/p>\n<p>Moreover, the USDA\u2019s \u201c<a href=\"https:\/\/www.ams.usda.gov\/grades-standards\/organic-standards#Livestock\" target=\"_blank\" rel=\"noreferrer noopener\">Organic<\/a>\u201d labeling does appear to permit vaccines for livestock used for meat, dairy and eggs, though the\u00a0<a href=\"https:\/\/www.goodharvestmarket.com\/content\/OrganicProductionandHandlingStandards.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">requirements<\/a>\u00a0state that animals must not be given hormones or antibiotics.\u00a0 A\u00a0<a href=\"https:\/\/www.ams.usda.gov\/sites\/default\/files\/media\/Organic%20Livestock%20Requirements.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">2013 Agricultural Marketing Service document<\/a>\u00a0states that \u201corganic livestock must be: \u2013 Produced without genetic engineering.\u201d\u00a0 However, the same document goes on to say that \u201cOnly a few drugs, such as vaccines,\u00a0<em>are allowed<\/em>\u201d for organically raised livestock.<\/p>\n<p>Furthermore, in many cases, labeling is not clear about the country from which meats originate.\u00a0<a href=\"https:\/\/www.ams.usda.gov\/rules-regulations\/cool\" target=\"_blank\" rel=\"noreferrer noopener\">Country of Origin Labeling (COOL)<\/a>\u00a0requirements were\u00a0<a href=\"https:\/\/www.ams.usda.gov\/sites\/default\/files\/media\/COOL%20final%20rule%20federal%20register%20version.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">dropped for beef and pork<\/a>\u00a0in 2016.\u00a0 COOL requirements remain in place for lamb, goat, chicken, and fish.\u00a0 Additionally, USDA regulations on meat, poultry and eggs have enabled \u201cProduct of USA\u201d labeling for animals born and raised in\u00a0<em>other countries<\/em>\u00a0and only\u00a0<em>processed<\/em>\u00a0in the U.S.\u00a0 However, in March 2023, the\u00a0<a href=\"https:\/\/www.fsis.usda.gov\/news-events\/news-press-releases\/usda-proposes-new-requirements-product-usa-label#:~:text=The%20proposed%20rule%20allows%20the,processed%20in%20the%20United%20States.\" target=\"_blank\" rel=\"noreferrer noopener\">USDA proposed a new rule<\/a>\u00a0to restrict labeling for \u201cProduct of USA\u201d or \u201cMade in the USA\u201d to be used on \u201cmeat, poultry and egg products\u00a0<em>only<\/em>\u00a0when they are derived from animals born, raised, slaughtered and processed in the United States.\u201d<\/p>\n<p><a href=\"https:\/\/www.coreysdigs.com\/food-supply-chain\/10-things-you-need-to-know-about-dna-rna-vaccines-for-livestock\/\" target=\"_blank\" rel=\"noopener\"><strong>Read More @ CoreysDigs.com<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>by The Sharp Edge, Corey&#8217;s Digs: 1. What are the different terms used for DNA or RNA-based veterinary biologics? Not all genetic technologies used in veterinary medicine fall under the categories of \u201cmRNA vaccines\u201d or \u201cmRNA gene therapies.\u201d\u00a0 There are other terms to look out for when it comes to genetic technologies for veterinary medicine.\u00a0 [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":357374,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[153989,154020,153910,153937,153951,153896,153880,153899,126466,153878],"tags":[156490],"_links":{"self":[{"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/posts\/357371"}],"collection":[{"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/comments?post=357371"}],"version-history":[{"count":1,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/posts\/357371\/revisions"}],"predecessor-version":[{"id":357372,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/posts\/357371\/revisions\/357372"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/media\/357374"}],"wp:attachment":[{"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/media?parent=357371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/categories?post=357371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sgtreport.com\/wp-json\/wp\/v2\/tags?post=357371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}